Rick Grobbee - Trials@Home & Tribulations with COVID19
Watch the insightful webinar ‘Trials@Home & Tribulations with COVID’ with Rick Grobbee!
Available at https://soundcloud.com/vitalhealth/rick-grobbee-trialshome-tribulations-with-covid19
In this podcast, we discuss the challenges posed by COVID19 to European healthcare systems, as well as the opportunity for harnessing Europe’s health data resources for smarter treatment and prevention. Rick is the professor of Clinical Epidemiology at University Medical Centre Utrecht and founder of the Julius Center for Health Sciences, currently employing roughly 500 staff. In 2017 he was knighted by the Dutch King, and given the Knight in the Order of the Dutch Lion.
One of the world’s leading Epidemiologists, Rick Grobbee has been at the centre multiple ground breaking projects of the Innovative Medicine’s Initiative that have focused on harnessing health data in new and unique ways. IMI’s GetReal, Big Data for Better Outcomes, and Big Data@Heart have all focused on improving research, but now, Rick Grobbee is leading the newly launched Trials@Home, that will move clinical trials from the hospital to the home, fundamentally changing the way clinical research is conducted.
CAPACITY: European registry of patients with COVID-19 including cardiovascular risk and complications
CAPACITY is a registry of patients with COVID-19 that require(d) cardiological care across Europe. It is an extension of the Case Record Form (CRF) that was released by the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) and WHO (World Health Organisation) in response to the emerging outbreak of COVID-19.
The aim of CAPACITY is to collect data regarding the cardiovascular history, diagnostic information and occurrence of cardiovascular complications in COVID-19 patients. By collecting this information in a standardized manner, CAPACITY can aid in providing more insight in (1) the establishment an incidence of cardiovascular complications in patients with COVID-19, and (2) the vulnerability and clinical course of COVID-19 in patients with an underlying cardiovascular disease.
For further information: https://capacity-covid.eu/
Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults
An interesting study led by Amitava Banerjee, Consultant Cardiologist and Associate Professor of Clinical Data Science (UCL)
Read the full paper here: https://bit.ly/2ULLr5z
COVID-19 and Cardiology
An array of valuables resources on COVID-19 and Cardiology is available on the website of the European Society of Cardiology (ESC) at https://www.escardio.org/Education/COVID-19-and-Cardiology
- ESC TV – Special Edition
- Insights from the Front Lines
- ESC Recommended Reading
- Additional Resources
The ESC also funds pertinent and useful, high-quality COVID-19 case reports in EHJ Case Reports.
Funding shall be attributed for all related and accepted articles submitted before: 15 May 2020.
For further information: ESC Funding for COVID-19 Related Case Reports
ACC.20/WCC Virtual
Due to the global pandemic, ACC.20/WCC in Chicago was cancelled
The "ACC.20/WCC Virtual" experience kicked off on Saturday, March 28 and offered three days of science and learning.
All content from live ACC20/WCCardio sessions is available on demand for 90 days at https://bit.ly/2vRsXs1
For further information: https://accscientificsession.acc.org/Registration-and-Hotels/ACC20-WCC-Coronavirus-COVID-19-Update
COVID-19: what does it mean for people with heart and circulatory disease?
For people who live with cardiovascular disease, their patient organisations at national level (heart foundations or associations) have compiled a wealth of scientifically sound advice to address misinformation in social media, and organised webinars where cardiologists answer their questions.
The European Heart Network (EHN) dedicated page http://www.ehnheart.org/covid-19.htm compiles links to reliable sources of information for cardiovascular patients.
BigData@Heart at EHRA 2020 - cancelled
EHRA 2020, the scientific congress of the European Heart Rhythm Association scheduled for Vienna on 29-31 March 2020, was cancelled to allow clinicians and hospitals to cope with the COVID-19 epidemic.
‘EHRA Essentials 4U’, a comprehensive hub of valuable and carefully selected resources, has been created to stay up to date on the latest scientific developments in heart rhythm.
Late breaking trials, publications based on abstracts, consensus documents, and more are available at
https://www.escardio.org/Sub-specialty-communities/European-Heart-Rhythm-Association-(EHRA)/Research-and-Publications/EHRA-Essentials4U